lamivudine has been researched along with Hematuria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angarano, G; Bellacosa, C; Coladonato, L; Fasano, M; Grattagliano, V; Lapadula, G; Leone, A; Maggi, P; Montinaro, V; Santantonio, T; Volpe, A | 1 |
| Beuers, U; Mühlhöfer, A; Samtleben, W; Thoenes, GH; von Appen, K; Weiss, M | 1 |
2 other study(ies) available for lamivudine and Hematuria
| Article | Year |
|---|---|
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study.
Topics: Adenine; Adult; Aged; Antiviral Agents; Bone Diseases; Drug-Related Side Effects and Adverse Reactions; Female; Glomerular Filtration Rate; Hematuria; Hepatitis B, Chronic; Humans; Hypophosphatemia; Kidney Diseases; Lamivudine; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Proteinuria; Vitamin D Deficiency | 2015 |
[Chronic HIV- and chronic HBV infection with hematuria and proteinuria].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Chronic Disease; Environmental Monitoring; Erythrocyte Count; Hazardous Substances; Hematuria; Hepatitis B; HIV-1; Humans; Lamivudine; Male; Occupational Exposure; Proteinuria; Zidovudine | 1998 |